Company news
Avenir Wellness Solutions Inc. news in 2018
Avenir Wellness Solutions Inc.'s news releases, calls and decks from 2018, newest first.
CURE Pharmaceutical Secures U.S. DEA Approval to Manufacture Cannabinoid-based Pharmaceuticals
November 26, 2018
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer
November 14, 2018
Prominent Biotech Investor Gene Salkind Adds Another $2M Investment in CURE Pharmaceutical
November 1, 2018
CURE Pharmaceutical to Present at CannX 2018 International Medical Cannabis Conference
October 10, 2018
CURE Pharmaceutical to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House
September 28, 2018
CURE Pharmaceutical Secures Patent for Oral Thin Film Containing Bioactive Cannabinoid Molecules
September 25, 2018
CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement
September 5, 2018
Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.
July 11, 2018
CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference
June 5, 2018
CURE Pharmaceutical to Showcase Company Growth at the 8th LD Micro Invitational
May 23, 2018
CURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery Production
May 1, 2018
CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules
April 4, 2018
CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year
April 3, 2018
UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
March 23, 2018
CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
March 23, 2018
CURE Pharmaceutical Announces Closing of $1 Million Bridge Financing and Prepares to Uplist to NASDAQ
March 23, 2018
Biopharmaceutical Veteran Joins CURE Pharmaceutical to Lead Manufacturing
March 14, 2018
CURE Pharmaceutical Adds Healthcare Luminary To Advisory Board, Secures $1 Million Investment as a Bridge to Uplisting
February 21, 2018
CURE Pharmaceutical Adds New VP of Strategy and Business Development
January 25, 2018
CURE Pharmaceutical Launches New Brand Focused on Patient Needs in Medication Delivery
January 4, 2018
CURE Pharmaceutical to Present at 2018 Biotech Showcase
January 3, 2018